| 24 May 2026 |
BAC Water |
8.7 |
5mg |
6.1mg |
+21.1% |
96.76% |
Lab E |
| 24 May 2026 |
Blend 300 (TRA/Mast P/Test P) |
9.4 |
250mg/ml |
228.5mg/ml |
-8.6% |
97.93% |
Lab G |
| 24 May 2026 |
Primobolan Oral (Methenolone Acetate) |
6.0 |
50mg |
60.2mg |
+20.3% |
95.24% |
Lab G |
| 24 May 2026 |
Retatrutide |
7.8 |
5mg |
5.4mg |
+8.0% |
99.40% |
No Label / Silver Crimp / Yellow Cap |
| 24 May 2026 |
AICAR |
7.1 |
5mg |
6.1mg |
+21.7% |
96.68% |
Lab C |
| 24 May 2026 |
Alprostadil |
7.7 |
30mg |
36.5mg |
+21.6% |
99.05% |
Lab A |
| 24 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
5.2 |
10mg |
10.6mg |
+5.8% |
95.85% |
Lab C |
| 24 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
4.2 |
15mg |
17.6mg |
+17.2% |
96.09% |
Lab D |
| 24 May 2026 |
DSIP |
4.2 |
20mg |
21.7mg |
+8.7% |
99.32% |
Lab E |
| 24 May 2026 |
EPO |
5.4 |
10mg |
12.2mg |
+21.5% |
96.26% |
Lab A |
| 24 May 2026 |
IGF-1 LR3 |
5.1 |
10mg |
12.2mg |
+21.7% |
99.37% |
Lab C |
| 24 May 2026 |
IGF-1 LR3 |
4.1 |
30mg |
30.6mg |
+2.1% |
95.78% |
Lab F |
| 24 May 2026 |
Pinealon |
4.1 |
10mg |
12.0mg |
+20.3% |
96.66% |
Lab F |
| 24 May 2026 |
Retatrutide |
6.2 |
20mg |
21.2mg |
+6.0% |
99.29% |
No Label / Copper Crimp / Clear Cap |
| 24 May 2026 |
BAC Water |
6.3 |
30mg |
27.2mg |
-9.4% |
98.38% |
Lab B |
| 24 May 2026 |
Sustanon 250 |
5.6 |
250mg/ml |
310.2mg/ml |
+24.1% |
97.47% |
Lab C |
| 24 May 2026 |
Retatrutide |
5.3 |
30mg |
24.7mg |
-17.7% |
99.90% |
Silver Label / Silver Crimp / Violet Cap |
| 24 May 2026 |
BAC Water |
5.5 |
15mg |
16.0mg |
+6.5% |
95.31% |
Lab F |
| 24 May 2026 |
PE 22-28 |
7.6 |
20mg |
17.3mg |
-13.3% |
96.62% |
Lab B |
| 24 May 2026 |
Test Cypionate |
9.0 |
300mg/ml |
315.5mg/ml |
+5.2% |
98.74% |
Lab G |
| 24 May 2026 |
BAC Water |
7.9 |
50mg |
59.4mg |
+18.8% |
96.52% |
Lab F |
| 24 May 2026 |
MGF |
7.5 |
2mg |
2.3mg |
+13.6% |
97.60% |
Lab F |
| 24 May 2026 |
Pinealon |
5.2 |
50mg |
48.4mg |
-3.2% |
98.35% |
Lab D |
| 23 May 2026 |
Retatrutide |
5.9 |
10mg |
11.3mg |
+13.0% |
99.90% |
No Label / Silver Crimp / Green Cap |
| 23 May 2026 |
Dianabol Oil |
6.7 |
250mg/ml |
226.5mg/ml |
-9.4% |
99.09% |
Lab A |
| 23 May 2026 |
MOTS-C |
5.1 |
2mg |
2.3mg |
+14.8% |
99.76% |
Lab B |
| 23 May 2026 |
Pancragen |
4.0 |
2mg |
2.3mg |
+15.1% |
95.59% |
Lab F |
| 23 May 2026 |
MGF |
6.0 |
50mg |
43.0mg |
-14.0% |
97.99% |
Lab F |
| 23 May 2026 |
Prednisone |
7.6 |
100mg |
122.3mg |
+22.3% |
98.13% |
Lab C |
| 21 May 2026 |
Tirzepatide |
3.8 |
5mg |
15.9mg |
+218.0% |
99.80% |
No Label / Silver Crimp / Clear Pink Cap |
| 21 May 2026 |
5-amino-1MQ |
8.3 |
10mg |
11.7mg |
+16.9% |
99.77% |
Lab B |
| 21 May 2026 |
Tirzepatide |
4.5 |
60mg |
66mg |
+10.0% |
98.96% |
No Label / Copper Crimp / Clear Cap |
| 21 May 2026 |
Tirzepatide |
7.5 |
30mg |
31.9mg |
+6.3% |
99.89% |
No Label / Copper Crimp / Clear Cap |
| 21 May 2026 |
EPO |
5.1 |
50mg |
51.8mg |
+3.5% |
95.70% |
Lab D |
| 21 May 2026 |
EPO |
6.0 |
2mg |
1.8mg |
-11.4% |
99.56% |
Lab A |
| 21 May 2026 |
Pancragen |
4.2 |
50mg |
53.0mg |
+6.0% |
97.14% |
Lab E |
| 20 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
4.1 |
5mg |
5.5mg |
+9.6% |
96.97% |
Lab E |
| 20 May 2026 |
EPO |
6.4 |
50mg |
58.8mg |
+17.6% |
98.03% |
Lab D |
| 20 May 2026 |
Estradiol Cypionate |
5.5 |
200mg/ml |
195.1mg/ml |
-2.5% |
95.16% |
Lab B |
| 20 May 2026 |
Humanin |
4.0 |
5mg |
4.9mg |
-1.2% |
97.98% |
Lab B |
| 19 May 2026 |
Livagen |
4.6 |
5mg |
5.6mg |
+12.0% |
95.15% |
Lab C |
| 17 May 2026 |
Livagen |
4.0 |
15mg |
15.5mg |
+3.1% |
97.77% |
Lab B |
| 17 May 2026 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
5.0 |
10mg |
9.4mg |
-6.3% |
96.99% |
Lab E |
| 17 May 2026 |
Prostamax |
4.0 |
15mg |
14.5mg |
-3.6% |
97.84% |
Lab D |
| 29 Jan 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
5.9 |
5mg |
5.5mg |
+10.3% |
95.32% |
Lab D |
| 26 Jan 2026 |
ACE-031 |
6.2 |
10mg |
10.0mg |
+0.1% |
99.07% |
Lab A |
| 26 Jan 2026 |
Dianabol Oil |
6.6 |
250mg/ml |
265.1mg/ml |
+6.0% |
95.96% |
Lab A |
| 26 Jan 2026 |
Hyaluronic acid |
8.2 |
15mg |
16.4mg |
+9.4% |
96.27% |
Lab A |
| 26 Jan 2026 |
PE 22-28 |
5.6 |
20mg |
19.9mg |
-0.7% |
99.26% |
Lab F |
| 26 Jan 2026 |
Pinealon |
4.3 |
50mg |
60.1mg |
+20.2% |
96.60% |
Lab B |
| 26 Jan 2026 |
Sustanon 250 |
7.6 |
300mg/ml |
337.8mg/ml |
+12.6% |
96.32% |
Lab G |
| 26 Jan 2026 |
Sustanon 250 |
4.0 |
300mg/ml |
272.8mg/ml |
-9.1% |
95.01% |
Lab D |
| 19 Jan 2026 |
GHRP-2 Acetate |
5.7 |
2mg |
2.0mg |
+1.1% |
96.54% |
Lab D |
| 9 Jan 2026 |
Prednisone |
6.4 |
10mg |
11.6mg |
+15.7% |
96.76% |
Lab F |
| 9 Jan 2026 |
SR9009 |
7.7 |
20mg |
20.3mg |
+1.6% |
98.15% |
Lab E |
| 6 Jan 2026 |
5-amino-1MQ |
8.7 |
10mg |
12.2mg |
+22.1% |
96.10% |
Lab F |
| 6 Jan 2026 |
Prednisone |
5.3 |
20mg |
18.6mg |
-7.2% |
99.01% |
Lab F |
| 6 Jan 2026 |
Primobolan Oral (Methenolone Acetate) |
6.3 |
50mg |
45.1mg |
-9.8% |
97.93% |
Lab E |
| 29 Dec 2025 |
AICAR |
4.0 |
20mg |
19.8mg |
-0.9% |
99.51% |
Lab B |
| 29 Dec 2025 |
DSIP |
7.8 |
5mg |
4.5mg |
-10.6% |
98.28% |
Lab G |
| 29 Dec 2025 |
Retatrutide 30mg Pen Kit |
8.2 |
20mg |
22.8mg |
+14.2% |
96.12% |
Lab A |
| 29 Dec 2025 |
Retatrutide 30mg Pen Kit |
6.5 |
50mg |
59.6mg |
+19.3% |
97.77% |
Lab C |
| 12 Dec 2025 |
Dianabol Oil |
5.9 |
250mg/ml |
252.1mg/ml |
+0.8% |
96.67% |
Lab G |
| 12 Dec 2025 |
Estradiol Cypionate |
9.6 |
100mg/ml |
87.7mg/ml |
-12.3% |
99.20% |
Lab C |
| 5 Dec 2025 |
KPV Oral |
8.7 |
25mg |
29.9mg |
+19.6% |
96.93% |
Lab C |
| 5 Dec 2025 |
MAPA (methyl alpha-phenylacetoacetate) CAS 101-97-3 |
6.8 |
10g |
8.8g |
-12.2% |
95.55% |
Lab F |
| 23 Nov 2025 |
Blend 300 (TRA/Mast P/Test P) |
8.7 |
100mg/ml |
114.2mg/ml |
+14.2% |
97.55% |
Lab B |
| 23 Nov 2025 |
Humanin |
5.3 |
20mg |
22.4mg |
+12.1% |
99.84% |
Lab B |
| 23 Nov 2025 |
MGF |
8.9 |
10mg |
10.3mg |
+3.1% |
99.63% |
Lab F |
| 23 Nov 2025 |
Retatrutide 30mg Pen Kit |
6.9 |
5mg |
5.3mg |
+5.6% |
98.92% |
Lab G |
| 17 Nov 2025 |
MGF |
7.4 |
2mg |
1.9mg |
-4.6% |
98.67% |
Lab F |
| 17 Nov 2025 |
PE 22-28 |
7.3 |
50mg |
53.5mg |
+6.9% |
98.46% |
Lab A |
| 14 Nov 2025 |
Cerebrolysin |
6.4 |
20mg |
24.3mg |
+21.6% |
95.25% |
Lab A |
| 14 Nov 2025 |
Humanin |
5.9 |
10mg |
11.4mg |
+13.6% |
98.83% |
Lab B |
| 5 Nov 2025 |
AICAR |
7.4 |
10mg |
10.6mg |
+5.6% |
99.69% |
Lab G |
| 5 Nov 2025 |
Livagen |
7.8 |
20mg |
22.5mg |
+12.6% |
98.83% |
Lab B |
| 5 Nov 2025 |
NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend |
4.0 |
15mg |
18.6mg |
+23.8% |
95.12% |
Lab D |
| 5 Nov 2025 |
Retatrutide 30mg Pen Kit |
8.0 |
20mg |
18.5mg |
-7.3% |
98.11% |
Lab D |
| 5 Nov 2025 |
Supertest 450 |
6.2 |
200mg/ml |
226.8mg/ml |
+13.4% |
98.70% |
Lab C |
| 4 Nov 2025 |
ACE-031 |
6.2 |
15mg |
17.9mg |
+19.5% |
98.88% |
Lab G |
| 4 Nov 2025 |
Dianabol Oil |
6.4 |
200mg/ml |
193.9mg/ml |
-3.0% |
97.46% |
Lab B |
| 17 Oct 2025 |
Estradiol Cypionate |
4.5 |
300mg/ml |
261.3mg/ml |
-12.9% |
96.42% |
Lab A |
| 17 Oct 2025 |
Humanin |
5.5 |
30mg |
29.3mg |
-2.5% |
99.89% |
Lab G |
| 9 Oct 2025 |
Supertest 450 |
5.0 |
300mg/ml |
303.4mg/ml |
+1.1% |
97.01% |
Lab C |
| 3 Oct 2025 |
Cerebrolysin |
10.0 |
15mg |
14.8mg |
-1.5% |
99.18% |
Lab A |
| 3 Oct 2025 |
Prostamax |
4.8 |
50mg |
51.3mg |
+2.6% |
96.52% |
Lab E |
| 3 Oct 2025 |
Prostamax |
7.0 |
5mg |
5.9mg |
+18.8% |
95.27% |
Lab E |
| 3 Oct 2025 |
Supertest 450 |
5.8 |
250mg/ml |
284.6mg/ml |
+13.9% |
96.54% |
Lab D |